- Opportunity and Forecast, 2016-2025
Gluten-free food is a food that excludes gluten and all its composite and hybrids. This kind of food is preferred by people who have gluten-related disorders including coeliac disease (CD), gluten ataxia, non-coeliac gluten sensitivity (NCGS), dermatitis herpetiformis (DH), and wheat allergy, as an effective treatment option. The gluten-free food should contain a good balance of nutrients such as macro and micro nutrients, which are sourced from meat, eggs, fish, rice, nuts, fruits, potatoes, and others. The goal is to achieve the same nutritional and biological value as gluten containing food.
Increase in prevalence of health problems and rise in awareness toward consuming healthy food are factors responsible to fuel the global gluten free food market. Commanding shelf space and growth in inventory of gluten free products supplements the growth. On the other hand, technological advancements and favorable policies of governing regulatory bodies are expected to create opportunities in the market. Geographically, the industry is divided into North America, Europe, Latin America, Asia-Pacific, Middle East, and Africa.
Major manufacturers operating in the industry are Kelloggs Company, Dr Schar., Boulder Brands, Freedom Foods Group, Hain Celestial, General Mills, Ener-G Foods, Raisio PLC, Genius Foods Ltd, Hero Group Ag, Valeo Foods, and Kraft Heinz Company. These key industry players have adopted various strategies, such as partnerships, collaborations, joint ventures, new product launches, expansion, merger & acquisition, and others to gain a competitive edge in the industry.
The global monoclonal antibody market was valued at $76,899 million in 2014 and is estimated to reach $214,922 million by 2025, registering a CAGR of 9.8% from 2018 to 2025. Read More >>